The new view on treatment of the infections of urogenital system of pregnant women with diabetes

The article discusses the application and effectiveness of drug Aflazin® manufactured by Valartin Pharma Ltd. as an antimicrobial therapy in pregnant women with diabetes mellitus in the II-III trimesters with uncomplicated urinary tract infection. In the course of the study, 91 women aged 18–40 yea...

Full description

Bibliographic Details
Main Authors: Т. В. Авраменко, А. В. Грибанов, И. В. Кривущенко
Format: Article
Language:English
Published: Publishing House TRILIST 2017-04-01
Series:Репродуктивная эндокринология
Subjects:
Online Access:http://reproduct-endo.com/article/view/101104
_version_ 1811334496543309824
author Т. В. Авраменко
А. В. Грибанов
И. В. Кривущенко
author_facet Т. В. Авраменко
А. В. Грибанов
И. В. Кривущенко
author_sort Т. В. Авраменко
collection DOAJ
description The article discusses the application and effectiveness of drug Aflazin® manufactured by Valartin Pharma Ltd. as an antimicrobial therapy in pregnant women with diabetes mellitus in the II-III trimesters with uncomplicated urinary tract infection. In the course of the study, 91 women aged 18–40 years were examined. Patients were randomized into 2 groups: 45 women entered group I (main), and group II (comparisons) – 46 pregnant women. All women received basic antibiotic therapy used in the clinic for the treatment of chronic nonspecific urinary tract infections. Additionally, pregnant women from the comparison group received Aflazin® 1 capsule 2 times a day for 15 days. Characteristics of the clinical course of the disease in pregnant women of both groups were homogeneous. The main signs of uncomplicated urinary tract infection were frequent painful urination in small portions, pain in the lower abdomen and in the lumbar region, an increase in body temperature. In 80% of cases, when studying the bacterial culture of the urine of pregnant women, microorganisms were detected in various associations. After using the drug Aflazin®, changes in the immunological reactivity of the organism were revealed due to a decrease in the level of CD4+-helpers and an increase in the percentage of phagocytosis. There was a change in the microbial spectrum of the organism towards the disappearance of the pathological flora in the urine. In the course of the study, a positive dynamics of the subjective and objective state of the examined women was obtained, a good tolerability and safety of the drug was noted. Complex therapy, supplemented with Aflazin®, had a significant positive effect on the overall condition of pregnant women. Efficacy of treatment as sufficient or high was noted in 45 (97.8%) cases from 46 in the comparison group and in 20 (44.4%) cases from 45 in the main group. The results obtained make it possible to recommend Aflazin® for the complex treatment of nonspecific urinary tract infections in women with diabetes mellitus in the II and III trimesters of pregnancy.
first_indexed 2024-04-13T17:09:50Z
format Article
id doaj.art-55a01b70e860417d92227cad54752cad
institution Directory Open Access Journal
issn 2309-4117
2411-1295
language English
last_indexed 2024-04-13T17:09:50Z
publishDate 2017-04-01
publisher Publishing House TRILIST
record_format Article
series Репродуктивная эндокринология
spelling doaj.art-55a01b70e860417d92227cad54752cad2022-12-22T02:38:20ZengPublishing House TRILISTРепродуктивная эндокринология2309-41172411-12952017-04-0134445210.18370/2309-4117.2017.34.44-5293195The new view on treatment of the infections of urogenital system of pregnant women with diabetesТ. В. Авраменко0https://orcid.org/0000-0003-1129-8204А. В. Грибанов1https://orcid.org/0000-0001-9384-3346И. В. Кривущенко2https://orcid.org/0000-0002-9323-381XSI “Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, UkraineSI “Institute of Pediatrics, Obstetrics and Gynecology NAMS of Ukraine” Nikolaev City Maternity Hospital № 2, UkraineSI “Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, UkraineThe article discusses the application and effectiveness of drug Aflazin® manufactured by Valartin Pharma Ltd. as an antimicrobial therapy in pregnant women with diabetes mellitus in the II-III trimesters with uncomplicated urinary tract infection. In the course of the study, 91 women aged 18–40 years were examined. Patients were randomized into 2 groups: 45 women entered group I (main), and group II (comparisons) – 46 pregnant women. All women received basic antibiotic therapy used in the clinic for the treatment of chronic nonspecific urinary tract infections. Additionally, pregnant women from the comparison group received Aflazin® 1 capsule 2 times a day for 15 days. Characteristics of the clinical course of the disease in pregnant women of both groups were homogeneous. The main signs of uncomplicated urinary tract infection were frequent painful urination in small portions, pain in the lower abdomen and in the lumbar region, an increase in body temperature. In 80% of cases, when studying the bacterial culture of the urine of pregnant women, microorganisms were detected in various associations. After using the drug Aflazin®, changes in the immunological reactivity of the organism were revealed due to a decrease in the level of CD4+-helpers and an increase in the percentage of phagocytosis. There was a change in the microbial spectrum of the organism towards the disappearance of the pathological flora in the urine. In the course of the study, a positive dynamics of the subjective and objective state of the examined women was obtained, a good tolerability and safety of the drug was noted. Complex therapy, supplemented with Aflazin®, had a significant positive effect on the overall condition of pregnant women. Efficacy of treatment as sufficient or high was noted in 45 (97.8%) cases from 46 in the comparison group and in 20 (44.4%) cases from 45 in the main group. The results obtained make it possible to recommend Aflazin® for the complex treatment of nonspecific urinary tract infections in women with diabetes mellitus in the II and III trimesters of pregnancy.http://reproduct-endo.com/article/view/101104pregnancydiabetes mellitusuncomplicated infectionsurogenital systemphytodrugsaflazin
spellingShingle Т. В. Авраменко
А. В. Грибанов
И. В. Кривущенко
The new view on treatment of the infections of urogenital system of pregnant women with diabetes
Репродуктивная эндокринология
pregnancy
diabetes mellitus
uncomplicated infections
urogenital system
phytodrugs
aflazin
title The new view on treatment of the infections of urogenital system of pregnant women with diabetes
title_full The new view on treatment of the infections of urogenital system of pregnant women with diabetes
title_fullStr The new view on treatment of the infections of urogenital system of pregnant women with diabetes
title_full_unstemmed The new view on treatment of the infections of urogenital system of pregnant women with diabetes
title_short The new view on treatment of the infections of urogenital system of pregnant women with diabetes
title_sort new view on treatment of the infections of urogenital system of pregnant women with diabetes
topic pregnancy
diabetes mellitus
uncomplicated infections
urogenital system
phytodrugs
aflazin
url http://reproduct-endo.com/article/view/101104
work_keys_str_mv AT tvavramenko thenewviewontreatmentoftheinfectionsofurogenitalsystemofpregnantwomenwithdiabetes
AT avgribanov thenewviewontreatmentoftheinfectionsofurogenitalsystemofpregnantwomenwithdiabetes
AT ivkrivuŝenko thenewviewontreatmentoftheinfectionsofurogenitalsystemofpregnantwomenwithdiabetes
AT tvavramenko newviewontreatmentoftheinfectionsofurogenitalsystemofpregnantwomenwithdiabetes
AT avgribanov newviewontreatmentoftheinfectionsofurogenitalsystemofpregnantwomenwithdiabetes
AT ivkrivuŝenko newviewontreatmentoftheinfectionsofurogenitalsystemofpregnantwomenwithdiabetes